Pertussis Vaccines
A Global Strategic Business Report
MCP35508
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (55)
3
CXO5
VICE PRESIDENT10
DIRECTOR25
MANAGER12
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Pertussis Vaccines Market to Reach US$8.3 Billion by 2030
The global market for Pertussis Vaccines estimated at US$6.4 Billion in the year 2024, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. DTaP Vaccine, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.7 Billion by the end of the analysis period. Growth in the Tdap Vaccine segment is estimated at 3.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 8.3% CAGR
The Pertussis Vaccines market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.
Global Pertussis Vaccines Market – Key Trends & Drivers Summarized
Why Is Pertussis Vaccination Regaining Urgency in Global Immunization Strategies?
Pertussis, commonly known as whooping cough, remains a significant public health threat despite decades of immunization programs. Caused by Bordetella pertussis, the disease poses severe risks to infants and immunocompromised individuals, often leading to hospitalization or fatal respiratory complications. The resurgence of pertussis in both high- and low-income countries is driving renewed focus on vaccine coverage, booster programs, and maternal immunization strategies.
The evolving epidemiology of pertussis—marked by increased incidence among adolescents and adults—has prompted healthcare agencies to revise immunization schedules. Recommendations now include adolescent boosters (Tdap), cocooning strategies for caregivers, and immunization during pregnancy to confer passive immunity to neonates. These policy shifts are supporting demand for both whole-cell (wP) and acellular (aP) pertussis vaccines, each with differing profiles of efficacy, reactogenicity, and public acceptance.
How Are Innovation and Reformulation Efforts Addressing Waning Immunity and Outbreak Management?
A major challenge in pertussis control is the waning immunity associated with acellular vaccines, which, although safer than whole-cell counterparts, provide shorter duration of protection. This has led to outbreaks even in highly vaccinated populations. Researchers and manufacturers are actively working on next-generation pertussis vaccines with improved adjuvants, extended immunogenicity, and broader strain coverage.
Novel formulations under development include live attenuated nasal vaccines, genetically detoxified pertussis toxins, and nanoparticle-based adjuvants aimed at enhancing mucosal immunity. These innovations are intended to strengthen herd immunity, especially in populations with high transmission potential such as school-aged children and healthcare workers. Additionally, advancements in combination vaccines (e.g., DTaP, Tdap-IPV-HepB-Hib) are streamlining immunization logistics and improving compliance in pediatric and adult populations.
Why Are Global Health Initiatives, Supply Chain Enhancements, and Policy Frameworks Vital to Market Expansion?
Global vaccination efforts led by organizations such as Gavi, WHO, and UNICEF continue to play a pivotal role in expanding pertussis vaccine access in low- and middle-income countries. These agencies support procurement, distribution, and cold-chain management while also funding education campaigns to reduce vaccine hesitancy. Public-private partnerships are further aiding vaccine affordability and localized production through technology transfers and licensing agreements.
Policy frameworks are also evolving to incorporate pertussis surveillance into national disease monitoring systems. Integrated immunization schedules, digital tracking tools, and catch-up campaigns are being implemented to address immunity gaps. Countries are increasingly prioritizing pertussis control within maternal and child health programs, boosting both demand and funding for vaccines. These systemic developments are improving market predictability and encouraging long-term investment by biopharmaceutical companies.
What’s Driving the Continued Growth of the Pertussis Vaccines Market Globally?
The growth in the pertussis vaccines market is driven by several factors including rising disease incidence, expansion of maternal immunization programs, and technological innovations in vaccine development. A key growth driver is the shift toward booster-based lifelong immunization strategies that extend coverage beyond infancy and target adolescents, adults, and seniors.
Moreover, the rising awareness of pertussis complications, improvements in diagnostic surveillance, and increased integration with combination vaccine platforms are further strengthening market momentum. As countries scale up efforts to meet global immunization targets and mitigate preventable deaths, pertussis vaccines remain central to national and international public health agendas.
With the ongoing emergence of pertussis variants, increasing healthcare investments in immunization infrastructure, and strong demand for safer, more effective vaccine formulations, the pertussis vaccines market is positioned for sustained global growth in both public health and private clinical sectors.
SCOPE OF STUDY
The report analyzes the Pertussis Vaccines market by the following Segments, and Geographic Regions/Countries:
Segments:
Type (DTaP Vaccine, Tdap Vaccine); End-Use (Vaccination Centers, Hospitals, Clinics, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Astellas Pharma Inc.; Bharat Biotech International Limited; Biological E. Limited; BioNet-Asia Co., Ltd.; Cadila Healthcare Ltd. (Zydus Cadila); Chiron Behring Vaccines Pvt. Ltd.; CSL Limited (Seqirus); GlaxoSmithKline plc; Green Cross Corporation; Haffkine Bio-Pharmaceutical Corporation Ltd.; ILiAD Biotechnologies, LLC; Indian Immunologicals Ltd.; Merck & Co., Inc.; Panacea Biotec Ltd.; Pfizer Inc.; Sanofi Pasteur; Serum Institute of India Pvt. Ltd.; Shanta Biotechnics Pvt. Ltd.; Sinovac Biotech Ltd.; Wuhan Institute of Biological Products Co., Ltd.
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| World Market Trajectories |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Pertussis Vaccines – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 48 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Incidence of Whooping Cough Outbreaks Propels Global Demand for Pertussis Vaccination Programs |
| Expansion of Childhood Immunization Mandates Throws the Spotlight on Combination DTaP and Tdap Vaccines |
| OEM Innovation in Acellular and Subunit Vaccine Technologies Enhances Safety and Reduced Side Effects |
| Growth in Booster Dose Recommendations for Adolescents and Adults Strengthens Multi-Dose Market Opportunity |
| OEM Development of Thermostable Formulations Supports Vaccine Reach in Low-Infrastructure Regions |
| Surging Focus on Maternal Immunization Strategies Fuels Market for Pregnancy-Specific Pertussis Vaccines |
| OEM Participation in National Immunization Programs and GAVI Initiatives Enhances Global Procurement Volumes |
| Rising Antigenic Drift and Pathogen Evolution Spurs Development of Updated and Broader Spectrum Formulations |
| OEM Collaboration With Research Institutions Accelerates Understanding of Waning Immunity and Long-Term Protection |
| Growth in Combination Vaccine Markets Supports Integrated DTaP-HepB-IPV Platforms |
| OEM Investment in Intranasal and Needle-Free Delivery Platforms Improves Pediatric Vaccine Compliance |
| Rising Global Birth Rates and Population Growth Sustain Routine Infant Immunization Demand |
| OEM Emphasis on Adjuvant Development Enhances Immune Response in High-Risk Populations |
| Expansion of Cold Chain Logistics and Last-Mile Delivery Systems Boosts Reach in LMICs |
| OEM Engagement in Serosurveillance and Disease Burden Studies Informs Regional Vaccination Strategies |
| Regulatory Fast-Track and WHO Prequalification Initiatives Accelerate New Product Approvals |
| Growth in Adolescent and Occupational Health Programs Enhances Adult Tdap Uptake |
| OEM Differentiation Through Reduced Dosing Schedules and Combined Coverage Enhances Cost Effectiveness |
| Increasing Government Stockpiling and Pandemic Resilience Planning Supports Supply Security |
| OEM Entry Into Hexavalent and Decavalent Vaccine Platforms Drives Future Combination Strategies |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Pertussis Vaccines Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| World Recent Past, Current & Future Analysis for Pertussis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Pertussis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Pertussis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for DTaP Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for DTaP Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for DTaP Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Tdap Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Tdap Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Tdap Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Vaccination Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Vaccination Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Vaccination Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| JAPAN |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| CHINA |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| EUROPE |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Pertussis Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Pertussis Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Pertussis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| FRANCE |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| GERMANY |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Spain Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Russia Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Pertussis Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Pertussis Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Pertussis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Australia Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| INDIA |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| India Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| South Korea Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Pertussis Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Pertussis Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Pertussis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Argentina Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Brazil Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Mexico Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Rest of Latin America Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Pertussis Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Pertussis Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Pertussis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Iran Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Israel Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Saudi Arabia Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| UAE Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Rest of Middle East Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
| AFRICA |
| Pertussis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Pertussis Vaccines by Type - DTaP Vaccine and Tdap Vaccine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Pertussis Vaccines by Type - Percentage Breakdown of Value Sales for DTaP Vaccine and Tdap Vaccine for the Years 2015, 2025 & 2030 |
| Africa Recent Past, Current & Future Analysis for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Pertussis Vaccines by End-Use - Vaccination Centers, Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Pertussis Vaccines by End-Use - Percentage Breakdown of Value Sales for Vaccination Centers, Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]